A
ACHV
Achieve Life Sciences, Inc. Common Shares
$7.00
Current Price
1W
1M
3M
6M
1Y
All
AI analysis
Read what the AI thinks of Achieve Life Sciences, Inc. Common Shares in the app.
Analyses are generated by AI from public data and are not investment advice.
Get the app
Key figures
Dividend per share
—
Yield
—
EPS
-$1.55
P/E
—
Data as of Oct 8
Why it matters for the long term
Over 10-20 years, what drives a share up is the growth of its profits (EPS) + reinvested dividends. The P/E tells you whether you are paying a lot or a little for that growth. In short: rising EPS + reasonable P/E + growing dividend = good long-term candidate.
Upcoming events
Quarterly earnings
Expected EPS: -$0.20
Nov 5
Posts
No posts about ACHV yet.
About Achieve Life Sciences, Inc. Common Shares
Achieve Life Sciences is a US biotech company developing cytisinicline, a plant-based drug meant to help people quit smoking and vaping. It has no established product business to speak of. The company spends money on clinical trials and regulatory work, and it funds that by selling new shares. Its value depends on getting the drug approved and sold.